Alpelisib, a PI3Ka inhibitor, effectively treats vascular anomalies with diverse genotypes and phenotypes.

Deeti J. Pithadia, Marina J. Heskel, Arman Shotayev, Sunit Davda, Rachelle Durand, Daniel Cooke, Josephine Czechowicz, Mary Lesh, Patricia Cornett, Kristin A. Shimano, Erin F. Mathes, Ilona J. Frieden, Beth Apsel Winger